Literature DB >> 18031995

Parental history of type 2 diabetes in patients with nonaffective psychosis.

Emilio Fernandez-Egea1, Brian Miller, Miguel Bernardo, Thomas Donner, Brian Kirkpatrick.   

Abstract

INTRODUCTION: We attempted to replicate two previous studies which found an increased risk of diabetes in the relatives of schizophrenia probands.
METHODS: N=34 patients with newly-diagnosed nonaffective psychosis and N=52 non-psychiatric controls were interviewed for parental history of Type 2 diabetes.
RESULTS: In a logistic regression model that included multiple potential confounders, psychosis was a significant predictor of Type 2 diabetes in either parent (p<0.04). DISCUSSION: We found an increased prevalence of Type 2 diabetes in the parents of nonaffective psychosis subjects. This association may be due to shared environmental or genetic risk factors, or both.

Entities:  

Mesh:

Year:  2007        PMID: 18031995      PMCID: PMC2703822          DOI: 10.1016/j.schres.2007.10.002

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  35 in total

Review 1.  The role of genetic susceptibility in the association of low birth weight with type 2 diabetes.

Authors:  T M Frayling; A T Hattersley
Journal:  Br Med Bull       Date:  2001       Impact factor: 4.291

Review 2.  Early programming of glucose-insulin metabolism.

Authors:  Susan E Ozanne; C Nicholas Hales
Journal:  Trends Endocrinol Metab       Date:  2002-11       Impact factor: 12.015

Review 3.  The thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Br Med Bull       Date:  2001       Impact factor: 4.291

4.  Family history of type 2 diabetes in schizophrenic patients.

Authors:  S Mukherjee; D B Schnur; R Reddy
Journal:  Lancet       Date:  1989-03-04       Impact factor: 79.321

5.  Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

Authors:  Gwyneth Zai; Daniel J Müller; Jan Volavka; Pal Czobor; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Journal:  Psychopharmacology (Berl)       Date:  2006-08-24       Impact factor: 4.530

Review 6.  Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

Authors:  Stephen C L Gough; Michael C O'Donovan
Journal:  J Psychopharmacol       Date:  2005-11       Impact factor: 4.153

7.  Minor physical anomalies in schizophrenic patients and their siblings.

Authors:  B Ismail; E Cantor-Graae; T F McNeil
Journal:  Am J Psychiatry       Date:  1998-12       Impact factor: 18.112

8.  Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype.

Authors:  D Gourion; C Goldberger; J P Olie; H Lôo; M O Krebs
Journal:  Schizophr Res       Date:  2004-03-01       Impact factor: 4.939

9.  Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.

Authors:  Martina C M Ryan; Patrick Collins; Jogin H Thakore
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

Review 10.  Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women.

Authors:  C Osmond; D J Barker
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

View more
  30 in total

1.  Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis.

Authors:  Emilio Fernandez-Egea; Clemente García-Rizo; Brian Miller; Eduard Parellada; Azucena Justicia; Miguel Bernardo; Brian Kirkpatrick
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

2.  Differences in glucose tolerance between deficit and nondeficit schizophrenia.

Authors:  Brian Kirkpatrick; Emilio Fernandez-Egea; Clemente Garcia-Rizo; Miguel Bernardo
Journal:  Schizophr Res       Date:  2008-11-28       Impact factor: 4.939

3.  Schizophrenia as a systemic disease.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2009-02-04       Impact factor: 9.306

4.  Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders.

Authors:  Suraj Sarvode Mothi; Neeraj Tandon; Jaya Padmanabhan; Ian T Mathew; Brett Clementz; Carol Tamminga; Godfrey Pearlson; John Sweeney; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2015-04-19       Impact factor: 4.939

5.  Glucose abnormalities in the siblings of people with schizophrenia.

Authors:  Emilio Fernandez-Egea; Miguel Bernardo; Eduard Parellada; Azucena Justicia; Clemente Garcia-Rizo; Enric Esmatjes; Ignacio Conget; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2008-06-02       Impact factor: 4.939

Review 6.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

Review 7.  Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis.

Authors:  Anne Marie Greenhalgh; Leticia Gonzalez-Blanco; Clemente Garcia-Rizo; Emilio Fernandez-Egea; Brian Miller; Miguel Bernardo Arroyo; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2016-10-17       Impact factor: 4.939

8.  Interventions for the metabolic syndrome in schizophrenia: a review.

Authors:  Evangelos Papanastasiou
Journal:  Ther Adv Endocrinol Metab       Date:  2012-10       Impact factor: 3.565

9.  Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives.

Authors:  Jaya L Padmanabhan; Pranav Nanda; Neeraj Tandon; Suraj S Mothi; Nicolas Bolo; Steven McCarroll; Brett A Clementz; Elliot S Gershon; Godfrey D Pearlson; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan
Journal:  J Psychiatr Res       Date:  2016-02-23       Impact factor: 4.791

10.  Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis.

Authors:  Emilio Fernandez-Egea; Miguel Bernardo; Christopher M Heaphy; Jeffrey K Griffith; Eduard Parellada; Enric Esmatjes; Ignacio Conget; Linh Nguyen; Varghese George; Hubert Stöppler; Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2009-03-11       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.